Evidence map›Paper›PMID 42682926›Full record

ArticleExperimental and therapeutic medicine2026

Shanshan Wang, Xutao Yang, Rochelle Mcgowan, Belinda Hodge, Daniel Shan, Nicolas Miller, Jiahong Tang

Abstract read
In one paragraph

Article in Experimental and therapeutic medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Shanshan WangDepartment of Hematology and Oncology, Hospital of Joint Logistics Support Force, Zhengzhou, Henan 450007, P.R. China.
Xutao YangDepartment of Hematology and Oncology, Hospital of Joint Logistics Support Force, Zhengzhou, Henan 450007, P.R. China.
Rochelle McgowanDepartment of Genetics, DICAT National Biomedical Computation Centre, Vancouver BC V6B 5A6, Canada.
Belinda HodgeDepartment of Genetics, DICAT National Biomedical Computation Centre, Vancouver BC V6B 5A6, Canada.
Daniel ShanDepartment of Genetics, DICAT National Biomedical Computation Centre, Vancouver BC V6B 5A6, Canada.
Nicolas MillerDepartment of Genetics, DICAT National Biomedical Computation Centre, Vancouver BC V6B 5A6, Canada.
Jiahong TangDepartment of Hematology and Oncology, Hospital of Joint Logistics Support Force, Zhengzhou, Henan 450007, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diffuse large B-cell lymphoma (DLBCL) is a common, aggressive subtype of non-Hodgkin lymphoma with poor outcomes. Identifying the primary molecular causes of DLBCL remains key. The present study examined the function of ribosomal protein lateral stalk subunit P0 (

Indexed as

AKT/mTOR signaling pathwayautophagydiffuse large B-cell lymphomaoxidative stressRPLP0

Identifiers

PMID42682926
PMCPMC13531328

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.